home / stock / fh:cc / fh:cc news

FH:CC News and Press, FILAMENT HEALTH CORP. From 12/06/23

Stock Information
Company Name: FILAMENT HEALTH CORP.
Stock Symbol: FH:CC
Market: AQNC
Menu
FH:CC FH:CC Quote FH:CC Short FH:CC News FH:CC Articles FH:CC Message Board
Get FH:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
FH:CC - FILAMENT HEALTH ANNOUNCES SIGNING OF DEFINITIVE AGREEMENT FOR CONVERTIBLE NOTE FINANCING, CLOSING OF C$900,000 NON-BROKERED PRIVATE PLACEMENT FINANCING, FOUNDER-LED NOTE OFFERING AND OTHER UPDATES RELATED TO UPCOMING SPECIAL MEETING AND PROPOSED BUSINESS

FILAMENT HEALTH ANNOUNCES SIGNING OF DEFINITIVE AGREEMENT FOR CONVERTIBLE NOTE FINANCING, CLOSING OF C$900,000 NON-BROKERED PRIVATE PLACEMENT FINANCING, FOUNDER-LED NOTE OFFERING AND OTHER UPDATES RELATED TO UPCOMING SPECIAL MEETING AND PROPOSED BUSINESS COMBINATION Canada NewsWire ...
FH:CC - Canadian Investment Regulatory Organization Trading Halt - FH

Canadian Investment Regulatory Organization Trading Halt - FH Canada NewsWire TORONTO , Dec. 6, 2023 /CNW/ - The following issues have been halted by CIRO: Company: FILAMENT HEALTH CORP. NEO Exchange Symbol : FH All Issues: Yes Reason: Pending...

FH:CC - Filament Health announces non-binding agreement for up to US$14 million in financing

(NewsDirect) Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to announce the signing of a non-binding term sheet for potential funding of up to US$14.4 million. The funding is in collaboration with an affiliate of Helena Partners Inc., a Cayman-Islands-based advisor ...

FH:CC - Filament Health receives authorization from Health Canada for Phase 2 clinical trial at UBC

(NewsDirect) Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to share the news that the company has received approval from Health Canada for a phase 2 clinical trial, which will be conducted at the University of British Columbia. This groundbreaking trial will fo...
FH:CC - FILAMENT HEALTH SIGNS NON-BINDING TERM SHEET FOR CONVERTIBLE NOTE IN CONNECTION WITH PLANNED BUSINESS COMBINATION

FILAMENT HEALTH SIGNS NON-BINDING TERM SHEET FOR CONVERTIBLE NOTE IN CONNECTION WITH PLANNED BUSINESS COMBINATION Canada NewsWire VANCOUVER, BC , Nov. 23, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company...

FH:CC - PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules

VANCOUVER, British Columbia, Nov. 15, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA)(OTCQB:PMBHF), a Canadian biotechnology company dedicated to the research and development of clinical-grade LaNeo™ MDMA and novel MDXX compounds, and Filament ...

FH:CC - FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS Canada NewsWire VANCOUVER, BC , Nov. 14, 2023 /CNW/ - Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) ("Filament" or the "Company"), a clinical-stage natural ...
FH:CC - FILAMENT HEALTH AND NASDAQ-LISTED SPAC JUPITER ACQUISITION CORPORATION ANNOUNCE FORM F-4 REGISTRATION STATEMENT DECLARED EFFECTIVE BY THE U.S. SECURITIES AND EXCHANGE COMMISSION AND MAILING OF DEFINITIVE PROXY STATEMENT

FILAMENT HEALTH AND NASDAQ-LISTED SPAC JUPITER ACQUISITION CORPORATION ANNOUNCE FORM F-4 REGISTRATION STATEMENT DECLARED EFFECTIVE BY THE U.S. SECURITIES AND EXCHANGE COMMISSION AND MAILING OF DEFINITIVE PROXY STATEMENT Canada NewsWire VANCOUVER, BC , Nov. 14, 2023 ...

FH:CC - Filament Health Announces Annual General Meeting Voting Results

Vancouver, British Columbia--(Newsfile Corp. - November 8, 2023) - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or the " Company "), a clinical‐stage natural psychedelic drug development company, is pleased to announce that shareholders overwhelmingly approved ...

FH:CC - Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications

Magdalena Biosciences, a joint venture recently formed by Jaguar Health and Filament Health Corp., is focused on developing novel, natural prescription medicines derived from plants for mental health indications Magdalena launches corporate website SAN FRANCISCO, CA / ACCESSWIRE / ...
Previous 10 Next 10